Pilot Study Comparing Early Conversion to Extended-Release Tacrolimus (ENVARSUS XR) to Immediate-Release Tacrolimus in Lung Transplant Recipients

Brief description of study

The purpose of this study is to determine the feasibility of early conversion to extended-release tacrolimus (ENVARSUS XR) compared to immediate-release (IR) tacrolimus in patients who receive a lung transplant. The study will also compare the impact of tacrolimus formulation on acute and chronic rejection, development of new antibodies against the transplanted lung, and kidney disease within the first-year post-lung transplant.




If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.